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Background: The prevalence of depression in stable COPD patients varies markedly, possibly
because of use of different scales. We aimed to assess depression using 2 different depression
scales and to examine the association between depression and poor exercise performance,
BODE index and muscle wasting in clinically stable COPD patients.
Methods: 122 stable COPD patients were assessed with the Centre for Epidemiologic Studies
Depression Scale (CES-D) and the Brief Assessment Schedule Depression Cards (BASDEC). We also
assessed patients with spirometry, bioelectrical impedance analysis, 6-minute walk distance
(6MWD), St George’s Respiratory Questionnaire (SGRQ) and MRC dyspnoea and Borg scales.
Results: The CES-D and BASDEC scales detected almost similar prevalence rates of depression
(21% vs 17%) with a Kappa coefficient of 0.68, p< 0.0001. The BASDEC scale detected more
depression in women and was more closely associated with dyspnoea than the CES-D. COPD
severity was associated with depression when using BODE scores but not when GOLD categories
were used. Each of the CES-D and BASDEC depression scores were associated with 6MWD after
adjusting for FEV1% predicted, gender, age and pack-years (pZ<0.0001 and 0.001, respec-
tively). Also, patients with a 6MWD< 350 scored significantly higher on both depression scales.
Wasted patients appeared to have higher depression scores, but the difference was statistically
insignificant.ODE, Multidimensional index (BZ Body mass index, OZObstruction of airways as measured by FEV1,
ale, EZ Exercise capacity as measured by 6MWT); BASDEC, Brief Assessment Schedule Depression
c Studies Depression; COPD, Chronic obstructive pulmonary disease; FFMI, Fat-Free Mass Index; FEV1,
d; FVC, Forced Vital Capacity; GOLD, Global Initiative for Chronic Obstructive Lung Disease; IQR,
, Litre; MRC scale, Medical Research Council Scale; 6MWD, 6-minute walk distance; 6MWT, 6-minute
PaCO2, Arterial carbon dioxide pressure; PaO2, Arterial oxygen partial pressure; Q, Quartile; SGRQ,
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Depression and its relationship 1573Conclusion: The administration of different depression scales may affect some of the character-
istics of depressed patients rather than the prevalence rate of depression. Depression was asso-
ciated with poor exercise performance and BODE index in COPD.
ª 2009 Elsevier Ltd. All rights reserved.Introduction
Chronic obstructive pulmonary disease (COPD) is an incur-
able disease causing major disability, morbidity, and
mortality.1,2 The pulmonary and extrapulmonary manifes-
tations of COPD seriously affect patients’ physical, social
and emotional states.1,3 It is therefore not surprising to find
a higher prevalence of depression in COPD patients than in
either healthy controls4,5 or even patients with other
chronic illnesses such as Parkinson’s disease, stroke,
arthritis and tuberculosis.5,6
The prevalence of depression in COPD patients has
varied significantly from 6 to 74%.7e14 This variation has
been explained mainly by differences in COPD severity,
assessment tools or patients’ characteristics.3,8 Impor-
tantly, the actual assessment tools being used may influ-
ence the final result as depression assessment scales differ
in their design, method of administration, number of items
and cut-off points. This may result in different depression
prevalence rates and variations in the relationships
between depression and the demographic characteristics of
the sample populations.
Depression may affect exercise capacity in COPD. The
area is not well studied although a limited number of
studies have found no relationship.5,15
There is generally a growing understanding of the
multisystem effects of COPD1 and currently the BODE index
(BZ Body mass index, OZObstruction of airways as
measured by FEV1, DZ Dyspnoea as measured by MRC scale,
EZ Exercise capacity as measured by 6MWT) is widely
accepted as a multidimensional assessment tool.16 Several
studies have reported a good association of BODE scores with
impairment in quality of life,17 limited physical activity18
and higher mortality.19 Depression is one of the major co-
morbidities of COPD which is associated with exacerba-
tions,20 poor prognostic outcome21 and mortality.22 For this
reason, the relationship of depression with BODE index
deserves investigation.
Low body mass index (BMI) is an independent prognostic
factor for mortality in COPD.23 Chavannes et al. found
a negative association between overweight (body mass
index (BMI)> 25) and depression (OR 0.4, 95% CI 0.2e0.8).10
A recent study showed that low fat-free mass index
(FFMIZ Fat-free mass/height2 (kg/m2)) is a significant
predictor of overall mortality, even in patients with normal
BMI.24 However, the association between the presence of
depressive symptoms and body weight and particularly
metabolically active tissues (fat-free mass) is poorly
understood and needs further study.
We examined the prevalence rate of depression in
patients with clinically stable COPD and whether it differed
according to the two different tools. We also assessed the
effect of using different depression scales on the correla-
tion between depression and the patients’ demographiccharacteristics. We explored the association between
depression and poor exercise performance, BODE index and
muscle wasting in patients with stable COPD.
Methods
Study subjects
Subjects were recruited from media advertising, a Medi-
cines Evaluation Unit, and the outpatient chest clinic at the
North West Lung Centre, South Manchester University
Hospital Trust, Manchester. COPD was diagnosed according
to GOLD guidelines25; all patients had to be clinically stable
at least 4 weeks before the time of the visit (Fig. 1).
Patients were excluded if they had current or recurrent
symptomatic ischemic heart disease, lung cancer, known
psychiatric illness, maintenance treatment with systemic
corticosteroids, active tuberculosis or insulin-dependent
diabetes mellitus. Patient recruitment extended from April
2006 to December 2007.
Prior to the visit patients were instructed to fast for 4 h
and withhold their short-acting bronchodilators for 6 h, all
other inhalers for 12 h, and to avoid alcohol and strenuous
exercise for 24 h. All participants gave written informed
consent. The Tameside and Glossop Local Research Ethics
Committee in Manchester approved the study.
Assessments
Bioelectrical Impedance Analysis (BIA) was performed in
the supine position at the beginning of the visit using
Bodystat 1500 (Bodystat Ltd, Douglas, UK). For defining
muscle-wasting, we used previously published Dutch
criteria; fat-free mass index (FFMI)< 16 kg/m2 for men and
FFMI< 15 kg/m2 for women.26
Spirometry was done according to the ATS/ERS Stan-
dardization Guideline27 using a Jaeger MasterScreen
spirometer (Jaeger Ltd, Hoechberg, Germany). Earlobe
capillary blood gases were measured according to the
method described by Spiro and Dowdeswell28 using a Radi-
ometer analyzer (Radiometer Medical A/S, Copenhagen,
Denmark).
Exercise capacity was measured using the 6-minute walk
test (6MWT) according to the ATS guideline.29 Before and
after completion of the 6MWT, dyspnoea and fatigue were
assessed using Borg scale30 and pulse rate and oxygen
saturation (Nonin Oximetry, Plymouth, USA) were
measured.
Health Status was measured by the St George’s Respi-
ratory Questionnaire (SGRQ).31 Dyspnoea was assessed
using the MRC dyspnoea scale.32 The multidimensional
(BODE) index was also used.16 For assessment of depression
two instruments were used: The Brief Assessment Schedule
Assessment Level
200 patients
145 Suitable patients
(received the patient’s information
sheet)
122 patients with clinically stable COPD
(for at least 4 weeks prior to the visit date)
attended the visit
55 patients were excluded due to:
current or recurrent symptomatic ischemic heart disease,
lung cancer, known psychiatric illness,
maintenance treatment with systemic corticosteroids,
active tuberculosis
or insulin-dependent diabetes mellitus.
Visits were rescheduled
due to: Exacerbations,
forgetting the visit time,
requesting for reschedule
23 patients
declined
Figure 1 Flow chart illustrating participant eligibility, exclusion and enrolment.
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logical Study on Depression (CES-D) Scale. BASDEC has been
used effectively in clinical assessment of depression33 in
COPD patients and other elderly patients9,33,34; it utilizes
the response at the bedside to each of its 19 cards with
‘true’, ‘false’ or ‘I do not know’. Two items are scored with
two points and the maximum score is 21. A score of seven or
above indicates possible case for depression. CES-D is
a reliable self-administered questionnaire35 and exten-
sively used in assessing depressive symptoms in elderly
healthy and ill populations. It consists of 20 negative and
positive items, and scores range from 0 to 60 and a score of
16 or higher indicates the presence of depressive symp-
toms. To avoid overlap and biased response, CES-D was
introduced after body composition measurement and the
BASDEC after lung function tests.
Statistical analysis
We used the chi-squared (c2) test and the independent
sample t-test (unless otherwise noted) for descriptive
analyses. A kappa coefficient was calculated to examine
the agreement between depression scales. Binary logistic
regression was used to assess sensitivity, specificity and
positive/negative predictive values of BASDEC against
CES-D. Non-parametric data were natural log transformed
or presented as median and interquartile range (IQR). We
used c2 test to investigate the categorical association
between depression and COPD severity as represented by
GOLD stages and BODE quartiles as published in the original
study by Celli et al.16
To examine the correlation between depression scores
and 6-minute walk distance (6MWD) and health status
univariate and multivariate analyses were performed using
either 6MWD or natural log transformed BASDEC or CES-D
scores as the dependent variable in COPD subjects. Binary
logistic regression was also used to investigate the asso-
ciation between exercise performance as a categorical
variable (cut-off of 350 m from the 6MWD) and depression,
adjusting for lung function (FEV1% predicted, PaO2 andPaCO2). We used c
2 test to examine the categorical
association of walking distance (<350 m vs 350 m) with
depression (depressed vs not depressed) and MRC grades
(grades 1,2,3 vs 4,5). The association of depression with
body mass and fat-free mass was examined using the c2
and independent sample t-tests. Significance was defined
at p-value 0.05. SPSS version 14 (SPSS Inc, USA) was
used.
Results
Patients’ characteristics
From 145 eligible patients, a total of 122 patients with
stable COPD were recruited. The mean age was 66 years
and women made up 39% of the sample; other character-
istics are shown in Table 1. The median BODE score was
2 with 6% of patients having a BODE score of 7 or more. Men
were older, had worse lung function and higher fat-free
mass index than women. Despite a higher cumulative
tobacco exposure more men than women had stopped
smoking (Table 1).
The prevalence of depression
According to the CES-D questionnaire 21% had depressive
symptoms and 17% were depressed according to the BASDEC
scoring system. Using depression defined by either one of
the questionnaires the prevalence of depression increased
slightly to 23.4%.
Table 2 shows that more women were depressed using
the BASDEC, but not the CES-D. In addition, BASDEC was
more sensitive than CES-D in detecting an association
between MRC dyspnoea grade and depression as shown in
Table 2. There was a good overall agreement between the
two questionnaires (kappaZ 0.68, p< 0.0001). Against
CES-D, BASDEC showed a high specificity 90.8% but lower
sensitivity 82.6%, a negative predictive value of 95.7% and
a positive predictive value of 68%.
Table 1 Baseline characteristics of the sample; mean values and standard deviations are shown unless otherwise noted.
All Men Women p-Value
Number 122 75 47
Age, yrs 66 6.7 67 6.4 64 7 0.03
Ex/current smokers 87/35 56/19 31/16 0.37
Pack/years median (IQR) 40 (25.8) 43.8 (30.4) 36 (19) 0.06a
FEV1% 52.5 18.5 48.9 17.7 56.6 18.7 0.03
FEV1/FVC 45.8 13.6 43 12.8 50.4 13.2 0.004
PaO2 (kPa) 9.2 1.4 9 1 9.4 1.4 0.07
PaCO2 (kPa) 5.2 0.58 5.2 0.6 5.1 0.6 0.25
BMI (kg/m2) 27.5 5.8 27.4 6 27.8 5.9 0.77
FFMI (kg/m2) 17.8 3.1 19.1 3 16.2 3.1 <0.0001
GOLD 1 6 (5%) 3 3 0.2b
GOLD 2 61 (50%) 34 27 0.2b
GOLD 3 39 (32%) 26 13 0.2b
GOLD 4 16 (13%) 12 4 0.2b
SGRQ total score 46 20 45.6 21 47.9 19 0.55
IQRZ Interquartile Range; FEV1%Z Forced Expiratory Volume over 1 second of predicted; FVCZ Forced Vital Capacity; PaO2Z Arterial
oxygen partial pressure; kPaZ kilo Pascal; PaCO2Z Arterial carbon dioxide pressure; BMIZ Body Mass Index; FFMIZ Fat-Free Mass
Index; GOLDZGlobal Initiative for Chronic Obstructive Lung Disease; and SGRQZ St George’s Respiratory Questionnaire.
a ManneWhitney U Test.
b c2-Test between all GOLD stages in males and females.
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There was a significant correlation between BASDEC and
CES-D scores and 6-minute walk distance (6MWD), rho
0.33 and 0.4, respectively, p< 0.001 for both. Two sepa-
rate modules of multivariate analyses showed that each of
the CES-D and BASDEC depression scores was indepen-
dently associated with 6MWD after adjusting for FEV1%
predicted, gender, age and pack-years (p 0.0001 andTable 2 Differences between patients with and without depress
else is noted.
All CES-D scale
Depressed Not de
Total 122 29 93
Gender (men/women) 75/47 15/14 60/33
Age (years) 66 6.7 63.7 7.8 66.9
Age 65/<65 77/45 13/16 64/29
FEV1% 52.2 18.4 50.4 16.4 52.4
FVC (L) 3 .9 2.8 0.8 3 .9
BMI (kg/m2) 27.5 (5.8) 28.7 6.5 27.2
FFMI (kg/m2) 17.9 (3.3) 17.76 3.4 18 3
6MWD (m) 353.7 69 325.6 65.4 354.6
Dyspnoea (Borg scale)
after 6MWT (median (IQR))
3 (3) 3 (1.5) 2 (2.4
Fatigue (Borg scale)
after 6MWT (median (IQR))
2 (3.5) 3 (3) 2 (2.5
MRC dyspnoea
scale (median (IQR)
1 (1) 2 (2) 1 (1)
SGRQ total score 46 20 63.8 16.1 41.1
pZ p-Value; CES-DZ Centre for Epidemiologic Studies Depression
FEV1%Z Forced Expiratory Volume over 1 second of predicted; FFMI
Minute walk distance, mZmeter; IQRZ Interquartile Range; and SG
a ManneWhitney U Test.0.001, respectively). Using categorical variables, patients
without depression performed better in the 6MWT than
depressed patients (Table 2). Using the 6MWD cut-off
point of 350 m (as in the BODE score) patients who walked
350 m had significantly lower depression scores than
those walking <350 m (Table 3). Logistic regression anal-
yses using 350 m as cut-off point was performed to assess
the impact of depression on exercise capacity after
adjusting for FEV1, PaO2 and PaCO2. In both modelsion; mean values and standard deviations are shown if nothing
BASDEC scale
pressed p Depressed Not depressed p
23 98
0.31 9/14 65/33 0.03
6.4 0.05 62.8 7.1 66.7 6.4 0.02
0.03 10/13 66/32 0.056
19.1 0.59 50.1 15 52.3 19.2 0.56
0.16 2.7 .8 3 .9 0.06
5.5 0.2 29 6.7 27.2 5.6 0.2
.3 0.7 18 3.3 17.6 3.7 0.6
 73 0.05 313.7 61.1 355 72.9 0.01
) 0.008a 3 (2) 2 (2.5) 0.004a
) 0.002a 3 (3) 2 (2.5) <0.0001a
0.07a 2 (2) 1 (1) 0.02a
18.3 <0.0001 66.4 13.8 41.9 19 <0.0001
Scale; BASDECZ Brief Assessment Schedule Depression Cards;
Z Fat-Free Mass Index; FVCZ Forced Vital Capacity, 6MWDZ 6-
RQZ St George’s Respiratory Questionnaire.
Table 3 Depression scores in groups according to exercise
capacity; median values and interquartile range are shown
6MWD 350 m 6MWD< 350 m p
CES-D score 6 (9) 12 (12) <0.0001
BASDEC score 2 (4) 4.5 (5) <0.0001
CES-DZ Centre for Epidemiologic Studies Depression Scale;
BASDECZ Brief Assessment Schedule Depression Cards;
6MWDZ 6-Minute walk distance; mZmeter; and pZ p-value.
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was a significant predictor of poor exercise performance,
OR 1.11 (95% confidence interval 1.05e1.18, p< 0.001)
and OR 1.25 (1.08e1.42, pZ 0.001), respectively. More-
over, in our 59 patients who walked< 350 m in 6MWT we
found only 15 with severely breathlessness (MRC grades
4,5), whereas 18 were depressed (using the BASDEC
scale), and only 6 (33%) of those 18 depressed patients
had MRC grades 4 or 5. Similarly, when using the CES-D
scale, we found that 20 patients (out of 59) were
depressed and only 8 of those depressed patients had MRC
grades 4,5.
Depression and BODE score
Spearman correlation showed a significant association
between scores of both depression scales (CES-D, BASDEC)
and total BODE scores (rhoZ 0.35, p< 0.001 and
rhoZ 0.22, pZ 0.016, respectively) but not FEV1%. Using
the BODE quartiles (Q1e4), patients with the most severe
disease (Qs 3&4) were more likely to suffer from depres-
sion (using CES-D) than those with milder disease (Qs
1&2), odds ratio (OR)Z 4.0 (1.5e10.6, pZ 0.007). A
similar association was seen for the BASDEC score,
ORZ 3.8 (1.4e10.4, pZ 0.02). This association between
severity of COPD and depression was not seen when using
GOLD stages (combined stages 3&4 compared to combined
stages 1&2), neither for the CES-D scale (ORZ 1.2Figure 2 Boxplot of the median (IQR) of the SGRQ total scores f
CES-D scales. The end of the whiskers represent the maximum
SGRQZ St George’s Respiratory Questionnaire; BASDECZ Brief
Epidemiologic Studies Depression Scale.(0.5e2.7, pZ 0.9)), nor the BASDEC scale (ORZ 1.1
(0.45e2.8, pZ 0.98)).
Depression and body composition
We found that 24% of our sample had muscle-wasting and
12% had a BMI< 21. Amongst the depressed patients, we
found that seven had muscle-wasting but only one patient
had a BMI< 21.
There was no significant association between BMI and
depression. Similarly, when using the cut-off value of either
BMI >25 or <21 no significant difference in rates of
depression (as continuous or categorical variable) were
detected. There was a tendency to patients with muscle-
wasting having higher depression scores than those without
wasting but the differences were statistically insignificant
(median BASDEC score 4 vs 2.5, pZ 0.16 and median CES-D
score 11 vs 9, pZ 0.4).
Depression and health status
Poor health status was significantly associated with
depression using either depression scale (pZ<0.0001)
(Fig. 2). This association remained unchanged after taking
FEV1% predicted, BODE score, smoking status, dyspnoea
and fatigue scores in Borg Scale (after 6MWT) into account
(pZ<0.0001). Depression alone (using either of the scales)
explained 31% of the health status and in the previous
adjusted model BASDEC explained 57% and CES-D 53% of the
variation in health status. Moreover, we found that
impairment of health status (total SGRQ score) was more
pronounced in depressed patients (using either CES-D or
BASDEC) than in patients who had MRC grades 4 or 5 (64, 66
and 61, p< 0.001, respectively).
Discussion
We found a significant prevalence of depression in mainly
moderate clinically stable COPD which was approximatelyor depressed and not depressed according to either BASDEC or
and minimum of SGRQ scores. IQRZ Interquartile range;
Assessment Schedule Depression Cards; CES-DZ Centre for
Depression and its relationship 1577similar when using two different scales. Depression was
significantly associated with limited exercise capacity and
the BODE index. Depressed patients had lower muscle mass
than not depressed but the difference was statistically
insignificant.
The prevalence of depression and the sample
characteristics
We found that depression is a common condition in clini-
cally stable COPD and its high prevalence changed only
slightly when using different scales. This finding does not
lend support to the suggestion that the employment of
different scales may affect the actual prevalence of
depression in COPD.3 We used the CES-D and BASDEC
depression screening scales and they are different in their
design, items number, scoring systems and administration
methods. The CES-D scale led to a slightly higher preva-
lence rate of depression than BASDEC (21 vs 17%); however,
both figures were consistent with other studies in which 20
(5)% of patients were depressed.3,4,12
Whereas the prevalence seems independent of the
questionnaire used, the use of different scales may affect
the association between gender and depression. In our
study only BASDEC showed that women were more
depressed than men. Three other studies have reported
similar findings.4,10,13 However, Cleland et al. used the
Hospital Anxiety and Depression Scale (HADS) and found no
association between gender and depression.12 This could be
due to questions in some of the screening tools relating
more to issues in depression such as sadness, being more
psycho-biologically related to women as suggested by Sal-
okangas et al.36 We found that depressed patients were
younger than those not depressed. Consistently, Cleland
et al. suggested that the burden of COPD on younger
patients seems higher as they may need to change life
style, retire early or find easier jobs12 whereas older
patients may accommodate more easily and ascribe some
of their limitations to the consequence of ageing.37
Clinical implication
The employment of a simple tool to assess depression is
important as depressed patients may not present their
depressive symptoms in a straightforward fashion.
Unscreened and consequently unmanaged depression may
result in further deterioration since depression is signifi-
cantly associated with exacerbations,20 relapse and
frequent admissions,21 and higher mortality.22 This may
result in increased consumption of primary and secondary
health care resources.
Administration of the BASDEC took less time than the
CES-D, and as in a previous study the patients responded
friendly to its cards.33 In addition, it was much easier and
quicker to score than the CES-D. It therefore seems suit-
able for employment in busy clinics. Moreover, the BAS-
DEC covered uniquely serious complaints such as suicidal
ideas. It seems intuitively important to screen for the
presence of suicidal thoughts in older people,38 particu-
larly if we consider the multidimensional persistent
burden of COPD.Depression, exercise capacity and quality of life
In our study depression was associated with poor exercise
capacity independent of our choice of depression
screening tool. Previously, Light et al. and Yohannes and
colleagues did not find a significant association between
depression and limitation in exercise capacity. In their
study Light et al. examined 45 men 15 and Yohannes et al.
studied only elderly COPD patients with short walking
distances.5 In addition to looking at association of
depression with distance walked we also examined
a 6MWD threshold of 350 m, the distance used as cut-off
value in the BODE score,16 and recently considered by
Cote et al. as a marker of poor exercise performance.39
Our study showed that patients with limited exercise
capacity had significantly higher scores on both depression
scales (Table 3). Also, our logistic regression model
showed that poor exercise performance was affected by
depression but not by the deterioration in lung function.
In addition, we found that only a third of depressed
patients with poor exercise performance would have been
identified using severe breathlessness with the MRC scale
(grades 4 and 5).
Impairment of quality of life is associated with both
depression20 and breathlessness.40 International guidelines
have advised that patients with higher MRC grades (usually
3e5) should be offered pulmonary rehabilitation.41,42 We
found that a substantial part of health status impairment
was explained by depression which had at least the same
impact on quality of life as severe dyspnoea (MRC grades
4,5). Thus, earlier detection of depression, treatment and
pulmonary rehabilitation may be very important. Studies
have showed improvement in depression after pulmonary
rehabilitation43,44 and some have indicated that interven-
tion with anti-depressant medications may improve exer-
cise capacity45,46 and quality of life.45
Depression and BODE index
Similar to many other studies we found no association
between level of FEV1 and depression scores.
4,10,15 Whereas
depression did not differ with GOLD stages, the multidi-
mensional BODE index was associated with depression. To
the best of our knowledge, this is the first study showing
a relationship between depression and BODE index. BODE
index is a multidimensional tool assessing uniquely the
multisystem effects of COPD.16 The association of low mood
with BODE may reflect the overall effects of the many
aspects of COPD and underlines the multisystem nature of
COPD and the limitations of relying on FEV1 only when
grading COPD.
Depression and body composition
In contrast to the findings of Chavannes et al.10 but
consistent with others4,5 we found no association between
BMI and depression. Our data suggested that depression was
more closely associated with depletion in the lean mass
than the whole body mass but these findings were not
statistically significant. Depression may lead to poor
appetite and limited mobility; all contributing to loss of
1578 K. Al-shair et al.fat-free mass47,48 which may subsequently lead to poor
exercise capacity.49
Our study was a cross-sectional study and cannot explain
mechanisms sufficiently as causeeeffect relationships
require longitudinal studies. However, our sample size was
fairly large with a balanced gender distribution and uni-
ethnicity (Caucasians), and our methodology was struc-
tured and our tools validated. Additionally, all the data
were collected on clinically stable patients on visits to our
centre.
Conclusion
In conclusion, we found a significant rate of depression in
COPD patients with mainly moderate clinically stable
disease which was only slightly affected by using different
tools for assessing depression. Depressed patients had poor
exercise performance and worse health status. Depression
was associated with BODE index, a significant predictor of
subsequent mortality in COPD. Thus, there is a need for
early identification and management of depression in
patients with COPD.
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